• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在尼日利亚的四家三级医疗机构中,使用 CD117、DOG1 和人表皮生长因子受体-2 生物标志物对胃肠道间质瘤进行临床病理和免疫组织化学特征分析。

Clinicopathological and immunohistochemical characterization of gastrointestinal stromal tumour at four tertiary health centers in Nigeria using CD117, DOG1, and human epidermal growth factor receptor-2 biomarkers.

机构信息

Department of Anatomic Pathology, University of Ilorin Teaching Hospital, Ilorin, Kwara State, Nigeria.

Department of Histopathology, University of Uyo Teaching Hospital, Uyo, Akwa Ibom, Nigeria.

出版信息

Ann Afr Med. 2023 Oct-Dec;22(4):501-507. doi: 10.4103/aam.aam_180_22.

DOI:10.4103/aam.aam_180_22
PMID:38358152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10775934/
Abstract

AIMS

Gastrointestinal stromal tumors (GISTs) are neoplastic lesions that primarily affect the digestive tract and develop from interstitial cells of Cajal. These lesions require histopathological and immunohistochemical characterization due to their malignant potential and personalized treatment. In this investigation, the sex, age, lesional sites of origin, histopathological types, the prevalence of human epidermal growth factor receptors (HER-2) expression, prognostic indices (based on tumor size and mitotic figures), expression of CD117 and DOG1, and characteristics of patients with GIST were all characterized.

MATERIALS AND METHODS

This was a retrospective cross-sectional analysis of GIST cases seen at four tertiary health-care centers in Nigeria over a 10-year period (2008-2017) and investigated utilizing histopathological and immunohistochemical (CD117, DOG1, and HER-2) methods.

RESULTS

In this investigation, there were twenty GIST cases. Notably, the majority (40%) of the cases had tumors with sizes between 7.0 and 8.0 cm; the stomach was the most frequent site (70%) and the spindle cell type of GIST was the most prevalent (80%) histopathological type. In addition, the stomach was significantly associated with GIST as an origin site (with a P = 0.001), and 100% and 50% of these tumors were immunoreactive with CD117 and DOG1, respectively.

CONCLUSIONS

In our study, GISTs most frequently develop in the stomach, and CD117 and DOG1 are essential for correctly diagnosing these tumors. However, HER-2 immunoreactivity is a predictive marker of survival for personalized care.

摘要

目的

胃肠道间质瘤(GISTs)是一种主要影响消化道并起源于 Cajal 间质细胞的肿瘤病变。由于其恶性潜能和个体化治疗的需要,这些病变需要进行组织病理学和免疫组织化学特征分析。在本研究中,对 GIST 的性别、年龄、病变起源部位、组织病理学类型、人表皮生长因子受体(HER-2)表达的流行率、预后指标(基于肿瘤大小和有丝分裂象)、CD117 和 DOG1 的表达以及患者特征进行了分析。

材料和方法

这是一项回顾性的横断面对尼日利亚四家三级医疗保健中心在 10 年内(2008-2017 年)观察到的 GIST 病例的分析,利用组织病理学和免疫组织化学(CD117、DOG1 和 HER-2)方法进行了研究。

结果

在本研究中,有 20 例 GIST 病例。值得注意的是,大多数(40%)病例的肿瘤大小在 7.0 到 8.0 厘米之间;胃是最常见的部位(70%),梭形细胞型 GIST 是最常见的组织病理学类型(80%)。此外,胃与 GIST 的起源部位显著相关(P=0.001),这些肿瘤中有 100%和 50%分别对 CD117 和 DOG1 呈免疫反应性。

结论

在我们的研究中,GISTs 最常发生在胃中,CD117 和 DOG1 是正确诊断这些肿瘤的关键。然而,HER-2 免疫反应性是个性化治疗中预测生存的一个标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdd/10775934/27c93a46ef09/AAM-22-501-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdd/10775934/24820b356965/AAM-22-501-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdd/10775934/4aca8a4b39d0/AAM-22-501-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdd/10775934/27c93a46ef09/AAM-22-501-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdd/10775934/24820b356965/AAM-22-501-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdd/10775934/4aca8a4b39d0/AAM-22-501-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bdd/10775934/27c93a46ef09/AAM-22-501-g003.jpg

相似文献

1
Clinicopathological and immunohistochemical characterization of gastrointestinal stromal tumour at four tertiary health centers in Nigeria using CD117, DOG1, and human epidermal growth factor receptor-2 biomarkers.在尼日利亚的四家三级医疗机构中,使用 CD117、DOG1 和人表皮生长因子受体-2 生物标志物对胃肠道间质瘤进行临床病理和免疫组织化学特征分析。
Ann Afr Med. 2023 Oct-Dec;22(4):501-507. doi: 10.4103/aam.aam_180_22.
2
CLINICOPATHOLOGICAL AND IMMUNO-HISTOCHEMICAL CHARACTERIZATION OF GASTROINTESTINAL STROMAL TUMOUR AT FOUR TERTIARY HEALTH CENTERS IN NIGERIA USING CD117, DOG1, AND HER-2 BIOMARKERS.在尼日利亚四家三级医疗机构中,使用 CD117、DOG1 和 HER-2 生物标志物对胃肠道间质瘤进行临床病理和免疫组织化学特征分析。
West Afr J Med. 2023 Nov 10;40(11 Suppl 1):S25.
3
Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors.在胃肠道间质瘤1上发现,这是肠外胃肠道间质瘤诊断的关键要素。
J Cancer Res Ther. 2019 Jan-Mar;15(1):138-141. doi: 10.4103/jcrt.JCRT_28_17.
4
Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.DOG1、CD117和PDGFRA在胃肠道间质瘤中的表达及其与临床病理特征的相关性
Asian Pac J Cancer Prev. 2012;13(4):1389-93. doi: 10.7314/apjcp.2012.13.4.1389.
5
DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.DOG1抗体在胃肠道间质瘤鉴别诊断中的应用:1840例病例研究
Am J Surg Pathol. 2009 Sep;33(9):1401-8. doi: 10.1097/PAS.0b013e3181a90e1a.
6
DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.DOG1 和 CD117 是胃肠道间质瘤诊断中的首选抗体。
Histopathology. 2010 Aug;57(2):259-70. doi: 10.1111/j.1365-2559.2010.03624.x.
7
DOG1 is a sensitive and specific immunohistochemical marker for diagnosis of canine gastrointestinal stromal tumors.DOG1是用于诊断犬胃肠道间质瘤的一种敏感且特异的免疫组织化学标志物。
J Vet Diagn Invest. 2015 May;27(3):268-77. doi: 10.1177/1040638715578878. Epub 2015 Apr 10.
8
The Diagnostic and Prognostic Utility of DOG1 Expression on Gastrointestinal Stromal Tumors.DOG1表达在胃肠道间质瘤中的诊断及预后价值
Turk Patoloji Derg. 2017;33(1):1-8. doi: 10.5146/tjpath.2016.01376.
9
ETV1 mRNA is specifically expressed in gastrointestinal stromal tumors.ETV1信使核糖核酸在胃肠道间质瘤中特异性表达。
Virchows Arch. 2015 Oct;467(4):393-403. doi: 10.1007/s00428-015-1813-9. Epub 2015 Aug 5.
10
Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour.胃肠道卡波西肉瘤:CD117表达及误诊为胃肠道间质瘤的可能性
Histopathology. 2008 Jun;52(7):816-23. doi: 10.1111/j.1365-2559.2008.03034.x.

引用本文的文献

1
circ_SMA4 promotes gastrointestinal stromal tumors malignant progression by sponging miR-494-3p/KIT axis and activating JAK/STAT pathway.环状 RNA(circRNA)SMA4 通过海绵吸附 miR-494-3p/KIT 轴和激活 JAK/STAT 通路促进胃肠间质瘤的恶性进展。
Sci Rep. 2024 Sep 24;14(1):22004. doi: 10.1038/s41598-024-73393-w.

本文引用的文献

1
Comprehensive review into the challenges of gastrointestinal tumors in the Gulf and Levant countries.对海湾地区和黎凡特国家胃肠道肿瘤挑战的全面综述。
World J Clin Cases. 2020 Feb 6;8(3):487-503. doi: 10.12998/wjcc.v8.i3.487.
2
Gastrointestinal Stromal Tumours (GIST): A Review of Cases from Nigeria.胃肠道间质瘤(GIST):来自尼日利亚的病例回顾。
J Gastrointest Cancer. 2020 Sep;51(3):729-737. doi: 10.1007/s12029-019-00318-6.
3
HER2 testing in gastric cancer: An update.胃癌中的HER2检测:最新进展
World J Gastroenterol. 2016 May 21;22(19):4619-25. doi: 10.3748/wjg.v22.i19.4619.
4
Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies.胃肠道间质瘤(GIST)的全球流行病学:基于人群队列研究的系统评价
Cancer Epidemiol. 2016 Feb;40:39-46. doi: 10.1016/j.canep.2015.10.031. Epub 2015 Nov 24.
5
MESENCHYMAL TUMOURS OF THE GASTROINTESTINAL TRACT: THE IMPORTANCE AND USE OF IMMUNHISTOCHEMISTRY IN CHARACTERIZING SPECIFIC TUMOUR ENTITIES.胃肠道间充质肿瘤:免疫组织化学在特定肿瘤实体特征描述中的重要性及应用
Niger J Med. 2015 Apr-Jun;24(2):150-4.
6
Imatinib (Glivec) and gastrointestinal stromal tumours in Nigerians.伊马替尼(格列卫)与尼日利亚人的胃肠道间质瘤
Afr J Med Med Sci. 2013 Dec;42(4):325-32.
7
Rare case of gastrointestinal stromal tumor of the anal canal.罕见的肛管胃肠道间质瘤病例。
J Cancer Res Ther. 2013 Oct-Dec;9(4):736-8. doi: 10.4103/0973-1482.126476.
8
Rare occurrence of mix stromal tumours: a case report of gastrointestinal and extra-intestinal stromal tumour on the jejunum and omentum of a nine year old girl from Adamawa State, Nigeria.罕见的混合性间质瘤病例:尼日利亚阿达马瓦州一名9岁女孩空肠和网膜上胃肠道及肠外间质瘤的病例报告
Ethiop J Health Sci. 2013 Jul;23(2):174-7.
9
HER2 testing in gastric cancer: a practical approach.胃肿瘤 HER2 检测:实用方法。
Mod Pathol. 2012 May;25(5):637-50. doi: 10.1038/modpathol.2011.198. Epub 2012 Jan 6.
10
Efficacy of imatinib mesylate neoadjuvant treatment for a locally advanced rectal gastrointestinal stromal tumor.甲磺酸伊马替尼新辅助治疗局部进展期直肠胃肠道间质瘤的疗效
J Korean Soc Coloproctol. 2011 Jun;27(3):147-52. doi: 10.3393/jksc.2011.27.3.147. Epub 2011 Jun 30.